Karen Flood

Calcium channel blockers enhance sac shrinkage after endovascular aneurysm repair

OBJECTIVE Sac shrinkage is a surrogate marker of success after endovascular aneurysm repair (EVAR). We set out to determine if any common cardioprotective medications had a beneficial effect on sac shrinkage. METHODS This retrospective observational study took place at Leeds Vascular Institute, a tertiary vascular unit in the Northern United Kingdom. The cohort comprised 149 patients undergoing EVAR between January 1, 2005, and December 31, 2008. Medication use was recorded at intervention (verified at study completion in 33 patients), and patients were monitored for 2 years. The main outcome measures were the effect of medication on sac shrinkage as determined by percentage change in maximal idealized cross-sectional area of the aneurysm at 1 month, 6 months, 1 year, and 2 years by linear regression model, in addition to 2-year endoleak and death rates determined by a binary logistic regression model. RESULTS After exclusions, 112 patients, who were a median age of 78 years (interquartile range, 78-83 years), remained for analysis. The median Glasgow Aneurysm Score was 85 (interquartile range, 79-92). At 2 years, mortality was 13.4%, endoleak developed in 37.5%, and significant endoleak developed in 14.3%. Patients taking a calcium channel blocker had enhanced sac shrinkage, compared with those not taking a calcium channel blocker, by 6.6% at 6 months (-3.0% to 16.3%, P = .09), 12.3% at 1 year (2.9% to 21.7%, P = .008), and 13.1% at 2 years (0.005% to 26.2%, P = .007) independent of other medication use, graft type, endoleak development, or death. CONCLUSIONS Enhanced sac shrinkage occurred after EVAR in patients taking calcium channel blockers. This warrants further study in other centers and at the molecular level.

Superficial Femoral Artery Rupture Following Angioplasty

This case reviews the various options for treating arterial rupture post-angioplasty including a discussion of principles to be adhered to in order to avoid such a situation in the first place.

Acute Renal Artery Occlusion and Trapped Renal Artery Catheter During Infrarenal AAA Stent Grafting

This case reviews the management of an occluded renal artery by the fabric of an aortic stent graft during an EVAR procedure.

Management of a Type 1B Endoleak Following EVAR

This case reviews the management of a distal type 1 endoleak following EVAR by embolization of the internal iliac artery. Displacement of a coil during the procedure is also discussed.

Superficial Femoral Artery Thrombosis Post-angioplasty

This case reviews the different approaches to dealing with acute thrombosis following angioplasty. An example of a thrombolysis regimen is given in addition to technique for thromboaspiration.

Fistula Rupture Post-fistuloplasty

This case outlines management of rupture of an arteriovenous fistula following balloon dilatation of a stenosis with a cutting balloon. Clinical and technical tips are provided for dealing with such a situation acutely.

Persistent Type 2 Endoleak Post-EVAR with Aneurysm Expansion

This case illustrates the treatment of a type 2 endoleak following fenestrated EVAR by coil embolization of the IMA.

Femoral Artery Pseudoaneurysm Treated with Percutaneous Thrombin Injection

This case illustrates the treatment of a post-femoral artery catheterization pseudoaneurysm with ultrasound-guided thrombin injection. Images illustrate the diagnosis and posttreatment appearances.

Migration of Common Hepatic Artery Stent Graft Occluding Right Hepatic Artery Flow

This case illustrates the technique of using adjacent/buttress stenting to keep open an artery compromised by a maldeployed stent graft.

Injury to Bowel Following Transplant Nephrostomy Insertion

This case illustrates the management of bowel perforation during transplant nephrostomy insertion. Tips for reducing the risk of this occurring are discussed.